Zomedica (ZOM) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free ZOM Stock Alerts $0.15 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call Transcriptmsn.com - April 2 at 4:06 PMQ4 2023 Zomedica Corp Earnings Callfinance.yahoo.com - April 2 at 8:30 AMZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023investorplace.com - April 1 at 9:06 PMZomedica reports Q4 resultsmsn.com - April 1 at 5:27 PMThe Next Millionaire-Makers: 3 Penny Stocks With Massive Upside Potentialinvestorplace.com - April 1 at 3:12 PMZomedica Pharmaceuticals Corp (ZOM)investing.com - March 15 at 7:52 AMSidoti & Company, LLC: Sidoti Events, LLC's Virtual March Small-Cap Conferencefinanznachrichten.de - March 12 at 11:26 AMZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferencesfinanznachrichten.de - March 12 at 8:22 AMZomedica Pharmaceuticals Corp. (ZOM)uk.finance.yahoo.com - March 1 at 2:46 PMZomedica Corp.: Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferencesfinanznachrichten.de - February 8 at 9:14 AMZomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferencesfinance.yahoo.com - February 8 at 9:14 AMZomedica Corp.: Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidationfinanznachrichten.de - February 6 at 5:00 PMLeading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)finance.yahoo.com - February 6 at 5:00 PMZomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ETfinance.yahoo.com - February 6 at 7:00 AMZomedica (NYSEAMERICAN:ZOM) Shares Down 5% marketbeat.com - February 6 at 2:21 AMZomedica Corp. (ZOM) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - February 4 at 8:05 AMOpen Letter to Zomedica Shareholders from your Chief Executive Officerfinance.yahoo.com - January 31 at 6:59 AMZomedica Corp Ordinary Sharesmorningstar.com - January 30 at 3:51 PMZomedica Corp.: Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidationfinanznachrichten.de - January 17 at 6:46 PMZomedica says Q4 revenue is expected to be over $7Mmsn.com - January 17 at 6:46 PMZomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")finance.yahoo.com - January 17 at 6:46 PM3 Breakout Penny Stocks Primed for Massive Gainsmsn.com - January 16 at 9:57 AMZomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024finance.yahoo.com - January 10 at 7:22 AMZomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiecefinance.yahoo.com - January 4 at 7:09 AMZomedica Corp. (ZOM) Stock Historical Prices & Data - Yahoo Financeca.finance.yahoo.com - December 22 at 10:18 PMZomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Diseasefinance.yahoo.com - December 18 at 7:54 AMZomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitionersfinance.yahoo.com - December 6 at 7:54 AMZomedica Pharma (ZOM) Earnings Dates & Reportsinvesting.com - November 14 at 4:36 PMZomedica Corp. (AMEX:ZOM) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 4:18 PMZomedica Corp (ZOM) Posts Record Q3 Revenue with Significant Gross Margin Improvementfinance.yahoo.com - November 13 at 5:19 PMZomedica reports Q3 resultsmsn.com - November 13 at 5:19 PMZomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologiesfinance.yahoo.com - November 13 at 5:19 PMZomedica Corp Registered Shs hosts conference call for investorsmarkets.businessinsider.com - November 4 at 1:00 PMZomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ETfinance.yahoo.com - November 2 at 9:12 AMZomedica Corp.: Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conferencefinanznachrichten.de - October 11 at 7:14 AMZomedica to Participate in the Lytham Partners Fall 2023 Investor Conferencefinance.yahoo.com - October 11 at 7:14 AMZomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Developmentfinance.yahoo.com - October 5 at 8:40 AMZomedica, Inc. to Present at the LD Micro Main Event XVIfinance.yahoo.com - September 27 at 6:39 AMZomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horsesfinance.yahoo.com - September 14 at 7:28 AMZomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfoliofinance.yahoo.com - September 5 at 5:04 PMZomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidityfinance.yahoo.com - August 10 at 6:10 PMZomedica Corp.: Zomedica to Present at Sidoti Virtual Investor Conference August 16-17finanznachrichten.de - August 8 at 7:37 AMZomedica to Present at Sidoti Virtual Investor Conference August 16-17finance.yahoo.com - August 8 at 7:37 AMZomedica to Host Second Quarter Financial Results Call on August 10finance.yahoo.com - August 4 at 5:10 PMZOM - Zomedica Corp.sg.finance.yahoo.com - July 1 at 3:18 PMZomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Servicesfinance.yahoo.com - June 9 at 8:00 AMZomedica (NYSEMKT: ZOM)fool.com - May 27 at 3:00 PMZomedica Exercises Option to Acquire Structured Monitoring Productsfinance.yahoo.com - May 8 at 8:30 AMZomedica to Host First Quarter Financial Results Call on May 11finance.yahoo.com - May 2 at 8:55 AMZomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)finance.yahoo.com - March 31 at 9:52 AM Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… ZOM Media Mentions By Week ZOM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZOM News Sentiment▼0.000.42▲Average Medical News Sentiment ZOM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZOM Articles This Week▼01▲ZOM Articles Average Week Get Zomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for ZOM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CYDY News ELTP News IMAB News CYBN News SYRS News INCR News AEON News COYA News VTGN News MCRB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:ZOM) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zomedica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
